Training new scientists to improve cancer treatment
Official title: Career Enhancement Program
Funded at University of Michigan at Ann Arbor · NIH-10917052 · Data updated 2026-11-12
The Career Enhancement Program at the University of Michigan is helping new scientists learn how to turn their lab discoveries into real treatments for cancer, so they can work together with doctors to find better ways to help patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | August 14, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $90,132 |
| NIH project number | 5P50CA269022-02 |
| Project ID | NIH-10917052 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include early career scientists and established researchers interested in cancer biology and treatment.
✕Less likely to help
Patients who are not involved in research or do not have a background in scientific investigation may not receive direct benefits from this program.
What this research studies
The Career Enhancement Program at the University of Michigan focuses on developing early career scientists who are dedicated to advancing cancer treatment through molecularly targeted radiosensitization. This program aims to mentor a diverse group of investigators, helping them transition from basic research to clinical applications that can directly benefit cancer patients. By fostering collaboration between basic scientists and clinicians, the program seeks to enhance the translation of laboratory discoveries into effective treatments. Participants will engage in pre-clinical testing and clinical trials to explore innovative approaches to cancer care.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment strategies that enhance the effectiveness of radiation therapy.
How similar studies have gone: Other research initiatives focused on training scientists in translational cancer research have shown promise in improving patient outcomes.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Ljungman, Mats — University of Michigan at Ann Arbor
- Study coordinator: Ljungman, Mats
Related research
Other NIH-funded projects on the same topics.
-
Expanding genetic testing for cancer risk in patients and families
This study is working to make it easier for cancer patients in Michigan to get genetic testing for cancer risk by improving how doctors gather family history and assess genetic risks, so that more people can receive the important evaluations they need.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Why the retina can sometimes heal itself and how we might help it heal
This NIH grant explores how inflammation and neural cells interact in the zebrafish retina to understand retinal neuron death and regeneration, with potential implications for human vision.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.